Bumetanide
NDC 81469-223, Bumetanide, tablet, from First Nation Group, LLC.
- Product NDC
- 81469-223
- Status
- Listed
- Labeler
- First Nation Group, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219291
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81469-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUMETANIDE2 mg/1
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81469-223-01 | 81469022301 | 100 TABLET in 1 BOTTLE (81469-223-01) |
| 81469-223-05 | 81469022305 | 500 TABLET in 1 BOTTLE (81469-223-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/79b77945-74a7-4cb5-8aa0-33a7babdf6d9
Use it
Look up 81469-223 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81469-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81469-223. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.